Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Layman, R.M.; Thomas, D.G.; Griffith, K.A.; Smerage, J.B.; Helvie, M.A.; Roubidoux, M.A.; Diehl, K.M.; Newman, L.A.; Sabel, M.S.; Hayman, J.A.; Pierce, L.J.; Hayes, D.F.; Schott, A.F.
    Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer (2007), Clin. Cancer Res., 13, 4092-4097.
    View publication on PubMed

Activating Compound

EC Number Activating Compound Comment Organism Structure
2.4.2.4 additional information thymidine phosphorylase expression is not up-regulated after docetaxel treatment Homo sapiens

Application

EC Number Application Comment Organism
2.4.2.4 medicine thymidine phosphorylase is a predictive biomarker in breast cancer Homo sapiens

Organism

EC Number Organism UniProt Comment Textmining
2.4.2.4 Homo sapiens
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
2.4.2.4 breast cancer cell
-
Homo sapiens
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
2.4.2.4 thymidine + phosphate
-
Homo sapiens thymine + 2-deoxy-D-ribose 1-phosphate
-
?